Advanced Evanescent-Wave Optical Biosensors for the Detection of Nucleic Acids : An Analytic Perspective by Huertas, César S et al.
REVIEW
published: 25 October 2019
doi: 10.3389/fchem.2019.00724
Frontiers in Chemistry | www.frontiersin.org 1 October 2019 | Volume 7 | Article 724
Edited by:
Ilaria Palchetti,










This article was submitted to
Analytical Chemistry,
a section of the journal
Frontiers in Chemistry
Received: 13 August 2019
Accepted: 10 October 2019
Published: 25 October 2019
Citation:
Huertas CS, Calvo-Lozano O,
Mitchell A and Lechuga LM (2019)
Advanced Evanescent-Wave Optical
Biosensors for the Detection of
Nucleic Acids: An Analytic
Perspective. Front. Chem. 7:724.
doi: 10.3389/fchem.2019.00724
Advanced Evanescent-Wave Optical
Biosensors for the Detection of
Nucleic Acids: An Analytic
Perspective
Cesar S. Huertas 1*, Olalla Calvo-Lozano 2, Arnan Mitchell 1 and Laura M. Lechuga 2
1 Integrated Photonics and Applications Centre, School of Engineering, Royal Melbourne Institute of Technology University,
Melbourne, VIC, Australia, 2Nanobiosensors and Bioanalytical Applications Group, Catalan Institute of Nanoscience and
Nanotechnology (ICN2), CSIC and the Barcelona Institute of Science and Technology, CIBER-BBN, Barcelona, Spain
Evanescent-wave optical biosensors have become an attractive alternative for the
screening of nucleic acids in the clinical context. They possess highly sensitive
transducers able to perform detection of a wide range of nucleic acid-based biomarkers
without the need of any label or marker. These optical biosensor platforms are very
versatile, allowing the incorporation of an almost limitless range of biorecognition
probes precisely and robustly adhered to the sensor surface by covalent surface
chemistry approaches. In addition, their application can be further enhanced by
their combination with different processes, thanks to their integration with complex
and automated microfluidic systems, facilitating the development of multiplexed and
user-friendly platforms. The objective of this work is to provide a comprehensive synopsis
of cutting-edge analytical strategies based on these label-free optical biosensors able to
deal with the drawbacks related to DNA and RNA detection, from single point mutations
assays and epigenetic alterations, to bacterial infections. Several plasmonic and silicon
photonic-based biosensors are described together with their most recent applications
in this area. We also identify and analyse the main challenges faced when attempting
to harness this technology and how several innovative approaches introduced in the
last years manage those issues, including the use of new biorecognition probes, surface
functionalization approaches, signal amplification and enhancement strategies, as well
as, sophisticated microfluidic solutions.
Keywords: biosensors, plasmonics, silicon photonics, microfluidics, nucleic acid analysis, epigenetics, surface
chemistry, clinical diagnosis
INTRODUCTION
Nucleic acids (NA) have a key function in many important cellular mechanisms, such as cell
differentiation, cell-division cycle, signal transduction, or metabolism (Fatica and Bozzoni, 2014;
Mens and Ghanbari, 2018; Mori, 2018). Our DNA is the best-known NA molecule and it contains
our genetic information. It is translated into proteins by the expression of messenger RNA
(mRNAs). However, this translation may be more complex than faithful transcription of the DNA
code to form proteins. Indeed, many species have cellular mechanisms that can edit the mRNAs by
alternative splicing processes, resulting in a significant increase in protein diversity (Liu et al., 2012).
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The gene regulation process is made even more complex
by the existence of a series of epigenetic mechanisms which
produce a phenotypic alteration in the expression of our genome
while keeping intact the DNA code. Among these epigenetic
processes can be found: the methylation of the DNA, nucleosome
repositioning, post-translational modification of histones, and
post-transcriptional gene regulation by non-coding RNAs (nc-
RNAs), such as micro-RNAs (miRNAs) (Yang et al., 2018).
This set of genetic and epigenetic mechanisms results in a
highly-structured gene regulatory network that serves the cells
to meet their specific function and create opportunities to
overcome environmental changes within the lifetime of an
individual organism.
In recent years, the analysis of NA for diagnostic purposes
have received special attention because of their prospective
application as biomarkers for the early and accurate detection
of infectious diseases (Fournier et al., 2013) and the molecular
diagnosis of a great number of clinical disorders, and in particular
cancer (Gingeras et al., 2005; Asadollahi et al., 2010; Lo et al.,
2010; Jansson and Lund, 2012; Benesova et al., 2013; Oltean and
Bates, 2013). Fortunately, NA biomarkers have been found to
circulate in diverse biological media, including serum, plasma,
saliva, and urine (Pös et al., 2018), so they can be targeted in
the development of new diagnostic approaches. For example,
circulating NAs are employed as target biomarkers in liquid
biopsies in substitution of the hazardous tissue biopsies. This
could overcome current clinical limitations in encompassing the
cancer cell genome and epigenome heterogeneity over time since
a liquid biopsy allows the recurrent monitoring of blood samples
in a less invasive manner. The information gathered from these
biomarkers can provide better insight into the evolutionary
dynamics of cancer. In fact, circulating tumor DNA (ctDNA)
seems to be a better indicator of the patient tumor status when
compared with clinical serological markers (Sanmamed et al.,
2015; Chang et al., 2016; Girotti et al., 2016). Other circulating
NAs such as mRNA and miRNA offer other level of information
(Climente-González et al., 2017; Anastasiadou et al., 2018; Koch
et al., 2018; Gai and Sun, 2019). Recent studies indicate that
there exist collaborative activities between these gene regulating
pathways that results in a common outcome (Murr, 2010;
Garcia-Gomez et al., 2018; Hanly et al., 2018). On the other
hand, NA molecules from bacteria and viruses are commonly
employed as markers indicative of the presence of pathogenic
microorganisms in infectious disease diagnosis (Fournier et al.,
2013). However, rather than simply attempting to identify
foreign NA, more insight may be gained by investigating the
different genetic/epigenetic mechanisms which can be affected
by the infection, potentially improving diagnosis by more
precisely determining infection status and progression or drug
susceptibility (Bierne et al., 2012; Ciarlo et al., 2013; Kathirvel
and Mahadevan, 2016). In addition to clinical diagnostics,
understanding the dynamics of these networks could positively
help and transform current medicine by the development of new
therapies where it may be possible to revert the altered cellular
process back to its normal state. For example, novel treatments
based on targeted therapy are being developed for melanoma
patients that harbor a BRAF mutation (Spagnolo et al., 2015).
Also, RG108, which is an inhibitor of DNAmethylation enzymes,
can suppress radio-resistance in esophageal cancer patients (Ou
et al., 2018). Likewise, several small molecules that regulate RNA
splicing have been acknowledged as good drug candidates for
treatment (Salton and Misteli, 2016), and personalized RNA-
based therapy has been proposed to decrease tumor growth in
pancreatic cancer (Gilles et al., 2018).
The most widely applied NA detection methods are those
based on Polymerase Chain Reaction (PCR) or sequencing
techniques (Cheng et al., 2018; Elazezy and Joosse, 2018; Zhao,
2019). PCR-based approaches allow the examination of small
quantities of material with high sensitivity in a time range from
few minutes to hours, which has greatly promoted the clinical
analysis of NA molecules. PCR-based approaches have enabled
the identification of specific NA sequence variations, such as:
point mutations or single nucleotide polymorphisms (SNPs)
(Zonta et al., 2016); DNA methylation (Fackler and Sukumar,
2018); alternative splicing variants (Harvey and Cheng, 2016);
miRNAs (Wang et al., 2019); as well as bacterial resistance
(Schmidt et al., 2019). On the other hand, next generation
sequencing (NGS) methods can perform genome-wide or exon-
wide analysis by massive parallel sequencing, allowing the
screening of copy number aberrations (Belic et al., 2016) or
SNPs (Gale et al., 2018). They have also been employed for the
identification of methylation sites (Wen et al., 2015). Sequencing
approaches enable to detect sequence variations that may take
place during the cancer treatment cycle without any previous
evidence of the primary tumour’s genome. In general, the
application of these methodologies for a rapid and efficient
population screening still face some limitations, such as the time
to complete the analysis, which usually ranges from days to hours
for DNA sequencing and PCR-based, respectively, and the large
volumes of sample required (Bellassai and Spoto, 2016).
Considering these facts, efforts should be directed into
the development of new technologies that enable the efficient
detection of genetic and epigenetic biomarkers involving simpler
protocols and lower reagent and sample consumption, which will
greatly reduce the cost and the time-to-result. In this context,
label-free optical biosensing devices offer a full range of attractive
alternatives due to their high-sensitivities and label-free detection
approaches, which can be further exploited thanks to their
versatility and capabilities for multiplex detection. In particular,
evanescent-wave biosensors have achieved great progress for NA
analyses (Carrascosa et al., 2016). They have been benefited
from improvements in biosensor fabrication and production
quality (Fernández Gavela et al., 2016; Soler et al., 2019), the
availability of new surface chemistry methods (Escorihuela et al.,
2015; Escorihuela and Zuilhof, 2017; Bañuls et al., 2019), the
availability of highly efficient probes for NA detection (Shi
et al., 2015; Nafa et al., 2016; Aviñó et al., 2019a), and new
approaches for the enhancement of the detected signal (Guo
et al., 2015). Also, the biosensor integration with microfluidics
permits the incorporation of different modules, including fluidic
transportation, sorting, mixing or separation methods for liquid
samples, and the automation of the complete analysis, which pave
the way for the full development of the so-called lab-on-a-chip
(LoC) platforms (Jung et al., 2015; Szydzik et al., 2015, 2017).
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The objective of this work is to give a comprehensive
overview of the analytical strategies that employ evanescent-
wave optical biosensors to deal with the complexities and
challenges of effective NA detection, with applications ranging
from identification of SPNs and epigenetic alterations in cancer,
to the detection of indirect modifications of NA processes caused
by bacterial infections. We also identify the main challenges
faced by this optical biosensor technology and describe several
innovative approaches in order to manage the existing challenges
limiting the performance of the current methods.
EVANESCENT-WAVE OPTICAL
BIOSENSORS
A biosensor is a self-contained device capable of providing
specific quantitative or semi-quantitative analytical information
using a selective biological or biomimetic recognition element
(biological receptor) which is in direct spatial contact with a
physical transducer (Soler et al., 2019) (Figure 1A). Optical
transducers are one of the most commonly used for NA detection
(Bora, 2013). They detect biological interactions by evaluating
the variations induced in the light properties, such as intensity,
wavelength, refractive index, or polarization (Sang et al., 2016).
They can be classified in label-based or label-free sensors. Label-
based usually detect changes in color or the presence of photons
generated at a particular wavelength by optical labels, such as
dyes/DNA intercalators or fluorescentmolecules. The label serves
as an indirect indicator of the presence of a concrete analyte.
Hybridization between a DNA probe and its specific target has
been detected by doping with chromophore molecules (Szukalski
et al., 2019). Fluorescence emission frommolecular beacons (Yao
et al., 2003), quantum dots (Chen et al., 2010a), or fluorescent-
labeled signal probes (Zhu et al., 2017) have also been employed
for NA detection. Although the use of optical labels is widespread
in NA analyses, these methods are inherently time-consuming
and can greatly increase the costs of the assays (Chen et al.,
2017). In addition, they are prone to sample losses in the labeling
process and, in the case of fluorescence, fluorophores are quite
sensitive to environment conditions, such as pH, and can be
bleached very fast, reducing the efficiency of the analysis (Sang
et al., 2016).
On the other hand, label-free optical biosensors enable
measurement of the physical properties of the analytes under
a label-free scheme, removing experimental ambiguity, and
allowing for more reliable analysis that require minimal assay
development (Chen et al., 2017). There is a vast repertoire of
label-free optical biosensors able to transform a specific biological
interaction into a quantifiable signal based on different working
principles, including the scattering of light or the generation
of an evanescent wave. Evanescent-wave biosensors have been
recognized as ideal candidates for NA evaluation without the
need of any molecular marker (Carrascosa et al., 2016). They
exploit the ability to confine an electromagnetic field within or
at the surface of dielectric and/or metal structures in the form
of localized or propagating electromagnetic modes with well-
defined optical properties. Part of the electromagnetic mode
extends beyond the surface into the external medium, as a so-
called evanescent field (Figure 1B). Variations in the refractive
index of the external medium just above the surface will
cause a change of the optical properties of the excited optical
mode through this evanescent field, resulting in a variation
of its effective refractive index and allowing for a quantitative
measurement. Due to the exponential decay of the evanescent
field in the external medium (usually few tens to few hundred
nanometres), only changes occurring in close proximity to the
surface will be sensed, with a natural filtering of background from
the surrounding medium. Evanescent detection does not become
weaker with reduced sample volume, instead it is proportional
to the concentration of analyte that come into contact with
the functionalised surface. This feature makes evanescent wave
biosensors particularly attractive for use with reduced sample
volumes and consequently reduced auxiliary reagent volumes
as well.
Evanescent-wave biosensors enable monitoring of
biomolecular interactions in real-time opening the possibility
of evaluating the affinity and kinetics of the interaction and can
contribute to a more concrete disease diagnosis. These type of
biosensors also benefit from versatility—theoretically, it would be
possible to selectively sense an almost limitless range of analytes
just by selecting the appropriate biological receptor. Currently,
new options for sensor transducers are emerging due to the
progress in nanofabrication technology which further provide
interesting opportunities for miniaturization, high-throughput
and low-cost production (Sagadevan and Periasamy, 2014; Sang
et al., 2016). Plasmonic and silicon photonics based biosensors
are among the most employed evanescent-wave biosensors
for the analyses of NAs with potential applicability in clinical
diagnosis (Ermini et al., 2014; González-Guerrero et al., 2016).
These biosensors have shown high detection sensitivities with
short response times. In this review, we will identify the main
challenges faced with plasmonic and silicon photonic biosensors
and summarize some of the most recent analytical strategies
developed for the analysis of NA biomarkers with these devices.
Plasmonic-Based Biosensors
Plasmonic-based biosensors constitute the most employed
evanescent-wave optical biosensors for NA analyses. Among
them, Surface Plasmon Resonance (SPR) biosensor is the
most advanced and mature technology (Soler et al., 2019).
SPR biosensors employ propagating surface plasmons that
oscillate collectively on a planar metal-dielectric interface. The
surface plasmon electromagnetic field propagation is constrained
vertically at this interface but is free to propagate laterally
along the film. The plasmon wave propagates with very specific
phase and attenuation properties which depend strongly on
the dielectric environment. The plasmon mode has a strong
evanescent field just above the surface of the metal facilitating
biosensing. For the plasmon excitation, a light source should be
effectively coupled to a thin metal layer, which is usually a 45–
50 nm thick film of gold. There are several configurations for
light coupling in SPR sensors to promote the excitation of the
surface plasmons, including prism coupling, waveguide coupling,
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FIGURE 1 | Different label-free optical biosensor based on evanescent wave. (A) Scheme of a biosensor. Reprinted from Carrascosa et al. (2016), Copyright (2018),
with permission from Elsevier. (B) Evanescent field principle. (C) SPR biosensor based on Krestchman configuration and different detection modes: (i) fixed-angle, (ii)
fixed wavelength, and (iii) fixed angle and wavelength (SPRi). (D) LSPR light coupling methods: (i) prism, (ii) extinction, and (iii) dark field. (E) Micro-ring resonator,
(F) MZI biosensor, and (G) BiMW biosensor designs and working principles.
and grating coupling (Soler et al., 2019). Among these, the prism-
based Krestschmann configuration harnessing Attenuated Total
Reflection (ATR) is the most widely employed (Figure 1C). In
this type of configuration, the surface plasmon is manifested
by a drop in the intensity of the light reflected, that strongly
depends on the refractive index of the dielectric. This surface
plasmon can be tracked to study any molecular interaction
taking place at the gold sensor surface by looking at changes in
the coupling angle of incidence or in the coupling wavelength.
Moreover, in SPR imaging (SPRi) systems, a multiplexed array
format can be achieved by fixing both, the wavelength or the
angle of the incident light, and measuring the intensity of
different spots using a CCD camera (Wong and Olivo, 2014).
SPR biosensors offer high sensitivities ranged between 10−5 and
10−6 refractive index units (RIU), corresponding to NA detection
limit within the pM-nM range with optimal biofunctionalization
conditions. Currently, there are already many different SPR
systems commercially available which are broadly deployed in
industry, hospitals, or academia (Prabowo et al., 2018). However,
they still involve bulk components and specialized procedures,
increasing their prices and complexity rendering them not
affordable for clinical setting. The new trends aim at reducing
the components’ costs, including novel light source technology
and detectors by harnessing current technology that can be easily
found everywhere, such as smartphones, to decrease the costs and
foster the portability of such biosensor devices (Liu et al., 2015c).
Parallelly, in the last decade, with the progress of
nanotechnology, a new generation of plasmonic sensors has
been introduced that can improve miniaturization, multiplexing
capabilities, and biosensor chip integration. These biosensors
use more sophisticated nanostructured metal films or so-called
nanoplasmonic structures with features on the scale of the
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wavelength of the incident light or even smaller. In these
nanoplasmonic structures, the surface plasmon can be confined
in all three dimensions inducing the non-propagating collective
oscillation of the metal free electrons termed localized surface
plasmon resonance (LSPR). This confinement provokes an
increment in the electromagnetic field near the structures that
rapidly falls off with distance and minimize LSPR biosensors
susceptibility to variations produced in the external media by, for
example, changes in temperature, and enhance their sensitivity
toward small analytes found at very small concentrations.
Sensitivity can be enhanced by an appropriate design of the
nanostructures, which can be exploited to promote different
resonance modes. In fact, these resonances can be modulated
to show highly reproducible strong nearfield enhancement and
sub-wavelength light confinement that enable to detect specific
molecular fingerprints (Dong et al., 2017). The simplicity of the
coupling of the light has fostered different detection approaches
(Figure 1D). Also, the facile device miniaturization provides
better opportunities for multiplexed device formats, highlighting
the superiority of nanoplasmonic biosensors over conventional
SPR ones. Furthermore, the performance of the nanostructures
during the detection of NAs can be predicted by the employment
of an universal model by taking into account the optical and
mass transport aspects, encouraging the development of devices
with maximized capabilities (Špačková et al., 2018).
Silicon Photonic Based Biosensors
Silicon Photonics biosensors are gaining momentum in the
diagnostic field. They consist of waveguides (i.e., structures
of conductive or dielectric material used to guide high-
frequency waves, such as electromagnetic waves in the case of
optical waveguides) that confine light in vertical and horizontal
dimensions but enable the propagation of light in a longitudinal
dimension with minimal loss of energy. Although optical
waveguides are normally used in integrated photonic circuits as
an optical analogy to electrical wires, they can be also employed as
high sensitive transducers in biosensor devices. These waveguides
are highly compact and can be easily miniaturized and patterned
in complex forms with extremely predictable behaviors. This
offers the opportunity to generate arrays of sensors within
the same photonic chip for multiplexed analysis. Silicon
photonics sensors are fabricated using conventional silicon
microfabrication techniques, including photolithography and
etching processes. This kind of fabrication allows for wafer-level
packaging, producing numerous sensors in the same fabrication
process with accurate precision and reproducibility, reducing
the time and the manufacturing costs (Fernández Gavela et al.,
2016). They have good optical properties, high stability with
temperature, inertness to many chemicals and solvents, low
surface roughness and a versatile chemical functionalization
(Escorihuela et al., 2014b). In silicon photonic biosensors, the
light is confined within a waveguide. The propagating light
modes (guided light modes) also exhibit an evanescent field
outside the waveguide surface. This portion of the evanescent
field of the guided light modes is sensitive to refractive index
changes at the sensor surface, which will produce a variation of
the phase velocity of the propagating mode. Several architectures
have been implemented for biosensing, among which optical
resonators and interferometers have been extensively employed
for the analysis of NA biomarkers (Carrascosa et al., 2016).
The most common optical resonator in the recent literature
is the micro-ring resonator. The main advantage of micro-
ring resonator-based biosensors reside in their compactness, the
ease of design and robust fabrication (Ciminelli et al., 2019).
In a conventional ring resonator arrangement, the light passes
through a straight waveguide which is coupled to a closed-
loop waveguide (micro-rings) (Fernández Gavela et al., 2016)
(Figure 1E). The surface of the ring structure is uncovered,
generating an evanescent field. In a ring resonator, the sensitivity
will increase depending on the number of round-trips supported
by the micro-ring, which is defined by the quality factor Q.
The biosensor intensity builds-up by multiple interactions with
the external environment and has reported sensitivities up to
10−6–10−7 RIU.
In interferometers, light is generally divided in two light
waves, one employed as a reference and the other one for sensing.
Only the sensing-light wave will be susceptible to variations
of the refractive index, which can be detected at the sensor
output. Technologies based on light interferometry appear to
be the most sensitive platforms reported. One of the most
common configuration employed for biosensing is the Mach-
Zehnder Interferometer (MZI) (Zinoviev et al., 2008). In its basic
configuration, MZI has an input single-mode waveguide with
power equally split between two arms by a Y-junction. One of the
two arms is exposed to the external medium to be sensed, while
the other is employed as a reference (Figure 1F). The two arms
are recombined through a second Y-junction into a single output
waveguide, resulting in an interference pattern with a determined
number of fringes of a certain amplitude (visibility factor)
depending on their sensitivity, which has been demonstrated
to be 10−7 RIU. However, the design and fabrication of the
MZI should be optimized to achieve a symmetric splitting
and recombination of the light, as well as balanced losses on
both the sensing and reference arms. The BiModal Waveguide
(BiMW) interferometer has been proposed as an alternative
to this configuration since it avoids light beam splitting and
recombination (Zinoviev et al., 2011). In this interferometer,
rather than the sensing and reference beams propagating along
physically separated arms of the MZI, sensing is achieved by
comparing two different supported modes (fundamental and
first order light modes) within the same straight waveguide
(Figure 1G). This results into a device with improved tolerance
to fabrication variations and a smaller footprint, opening the
possibility to fabricate more sensors in the same area, with
a consequent increase in the reproducibility and reliability of
the sensing evaluations. In the BiMW, the first order mode
is far more evanescent than the fundamental mode. Hence,
during the biointeraction event, the fundamental mode would
act as the reference wave being only weakly influenced by
the biointeraction, while the first order mode will be strongly
influenced by the refractive index changes occurring within the
evanescent field. The interference of both modes produces a
phase variation signal similar to the MZI, which is collected at
the end of the waveguide. This configuration has demonstrated
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a bulk sensitivity of 10−8 RIU, becoming one of the most
sensitive interferometers described in the literature for label-
free direct detection of NAs (Huertas et al., 2016b, 2017).
Silicon photonic biosensors based on MZI and BiMW are totally
integrated devices that include the light beam splitting and
recombination, providing further stabilization to mechanical
vibrations (González-Guerrero et al., 2016). However, the
interferometric signal has a sinusoidal trend and can lead to
ambiguity during signal interpretation. These drawbacks been
overcome at the expense of post-processing of the read-out
signal with the use of different innovative forms of modulation
based on all-optical phase modulation (Dante et al., 2012) or
optical frequency combs (Knoerzer et al., 2019), improving the
performance of these integrated photonic biosensors.
Further advances in the complete integration of the optical
components into the same silicon chip is being pursued in
order to satisfy the necessity of point-of-care systems for their
use in clinical settings or for healthcare diagnosis applications.
Auxiliary equipment such as signal acquisition devices or high
current power supplies occupy significant volume of space, which
detracts from the benefits provided by the micro/nano scale of
these devices. Efforts are directed to the integration of multiple
functions, such as on-chip lasers. Different materials, either alone
or in hybrid approaches, have been employed for the integration
of lasers in silicon chips, such as germanium (Wirths et al.,
2015; Margetis et al., 2018), or group III/V materials (Roelkens
et al., 2015). While the former increases the power supply of
the biosensors, the latter maximize the density of integration
and, therefore, the portability (Luan et al., 2018). Because they
are compatible with complementary metal oxide semiconductor
(CMOS) fabrication, different detectors based on these type of
materials have been also proposed (Luan et al., 2018).
Challenges in Label-Free Optical
Biosensing of Nucleic Acids
Sensitivity is one of the main challenges in the detection of NA.
Not only are these biomarkers present in low concentrations in
real samples, but in most cases, they are related to subtle changes
in gene expression. In addition, the dynamic range of recognition
usually should cover a wide range of NA concentrations, such as
the case of miRNA analysis, where the over-expression or sub-
expression usually cover from nanomolar (nM) concentrations
to attomolar (aM) (D’Agata and Spoto, 2019). The outstanding
sensitivity required for NA analysis can be obtained by the
combination of highly sensitive biosensor transducers and
signal pre- and/or post-amplification approaches by PCR-
based methods or signal enhancers, such as nanomaterials or
DNA/RNA binding proteins. However, this sensitivity not only
depends on the physical transductionmechanism of these devices
but is vastly dependent on the biofunctionalization approach and
the quality of the selected biorecognition element (González-
Guerrero et al., 2016). The bioreceptor layer must interact with
sufficient specificity and selectivity with the target NA. It is
highly dependent on both, the proper covalent attachment to the
surface, and the hybridization event. Successful sensing must also
ensure discrimination between homologous sequences that could
require differentiation between a single nucleotide mismatch.
The nature of the NA is another aspect that should be
considered. RNA molecules are easily degradable by RNases.
Their half-life is constrained by the presence of these enzymes
and the detection methodology may require the inclusion of
purification steps (Baratchi et al., 2014). In addition, target
lengths could also complicate the detection process. While short
sequences may produce lesser sensor signal increments, thereby,
worse limit of detection (LOD), long sequences are more prone
to generate secondary structures by self-loop formation by base
paring, and the target sequence may be hindered. In the case of
DNA biomarkers, they usually are long and doubled stranded
sequences, being difficult to capture. In this case, detection
approaches may need to include the previous use of an enzyme
restriction protocol, denaturation steps or special probe designs
that enable double strand DNA (ds-DNA) capture.
The study of gene regulation pathways implies both, the
detection and quantification of the NAmolecules that participate
in such processes, i.e., DNA fragments, mRNA isoforms
generated by alternative splicing or micro-RNA regulators,
and the recognition of the epigenetic markers such as the 5-
methylcytosines in DNA. In addition, although independent
analysis of each type of NA biomarker are proven to enhance
the sensitivity and specificity of the assays in comparison
other circulating biomarkers (Bratman et al., 2015), multiplexed
biomarker detection will definitely help to further understand the
dynamics of a concrete disease and increase the sensitivity of the
diagnosis (Sullivan et al., 2019).
Finally, sample pre-treatment and manipulation are critical
for NA biosensing. Direct evaluation of biofluids such as blood
or urine remains challenging and is yet to be effectively solved
for direct label-free evaluation (Soler et al., 2019). The high
amount of proteins and lipids present in blood can adsorb
onto the sensor surface and usually lead to high background
signals, obscuring the specific signal of the target and hindering
their recognition. Therefore, the biosensor should be provided
with a low-fouling biosurface in order to prevent non-specific
adsorptions. In addition, NAs are present not only in circulation,
but also inside cells, exosomes, or organelles. In order to avoid
cross-contamination, samples may require the separation of
specific cells, RNAs, DNAs, etc. (Gai and Sun, 2019). Circulating
DNA needs better plasma separation methods because current
protocols include centrifugation steps that are too aggressive,
promoting circulating cell disruption and, therefore, the release
of undesired NA material. In addition, this extraction should
be performed right after sample extraction to prevent from any
contamination of DNA from circulating blood cells. Here, the
integration of the optical biosensor with microfluidic lab-on-a-




In label-free optical biosensors, the biorecognition layer at the
surface of the transducer is of paramount importance. The final
sensitivity and specificity of a biosensor are directly related to the
activity of the immobilized molecules and the accessibility of the
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specific targets. In the development of NA biosensors there are
two key steps: (i) the biorecognition element design, responsible
of the system selectivity; and (ii) the surface functionalization
chemistry, which should ensure: a good surface coverage; proper
accessibility of the target to the immobilized biolayer; low
non-specific binding; and good reproducibility and robustness
(Bañuls et al., 2013).
Biorecognition Elements in Nucleic
Acid-Based Biosensors
The biorecognition element must ensure high selectivity to
enable single-nucleotide resolution, homologous sequences
discrimination, and negligible cross-hybridization from non-
specific NA molecules present in the same sample. In NA
biosensors, the conventional biorecognition element is a single-
stranded DNA (DNA probe) with a specific sequence of
nucleotides of around 9–50 bases, which hybridizes to a
complementary NA molecule. Whereas, antibody production
involves their induced expression by the injection of a specific
antigen into laboratory or farm animals/cells and their eventual
recovery (Chon and Zarbis-Papastoitsis, 2011), DNA is an easily
synthesizable biorecognition element. Current biotechnological
methods permit the in-vitro production of synthetic NAs
with the desired sequence in large amounts and with high
degree of purity (Hughes and Ellington, 2017). They can
be customized depending on their application by introducing
different modifications in both the 5’ and the 3’ ends. Thus,
structural end-modifications can be introduced in the DNA
probe sequence for their direct immobilization over different
types of inorganic materials to generate functional surfaces
for NA detection at a very low manufacturing cost. In the
design of ss-DNA probes, three factors must be considered:
(i) the functional group that will allow the attachment of
the probe to the sensor surface; (ii) a vertical spacer to
improve accessibility, and (iii) the sequence itself (Figure 2A).
A wide variety of functional groups are available for synthetic
oligonucleotides depending on the surface chemistry selected
for the attachment. Short oligonucleotides modified by amino,
thiol, hydrazide, phosphorothioates, or biotin are commonly
used for DNA immobilization (Zourob, 2010). End modification
of DNA probes not only introduces a site-specific group for
their oriented covalent attachment, but also allows insertion
of a spacer between the probes and the surface. This vertical
spacer improves the mobility of the immobilized probes and
their accessibility by the complementary target sequences. They
also move the DNA sequence away from the sensor surface,
reducing the adsorption and steric effects (Carrascosa et al.,
2012). Different vertical spacers can be introduced, such as a
chain of 6 or 12 carbons (C6 or C12, respectively) (Schmieder
et al., 2016) or poly-thymine (polyTm) sequences of different
lengths (Huertas et al., 2017, 2018) which acts as a vertical spacer
due to the low affinity of thymine bases for gold surfaces (Opdahl
et al., 2007).
For the selection of the probe sequence there are available
many commercially manufactured and well-understood codes
that help to tailor the probe-target stability of a given application
(Ermini et al., 2011). An important challenge is the presence
of regions that can assume conformations by self-hybridization
and may hide the binding sequence of interest. To avoid self-
hybridization, probe length and C-G content are determinant
factors. Probes containing between 15 and 25 bases permit
strong hybridization while avoiding self-complementarities and
reducing the likelihood of cross-hybridization from undesired
molecules (Ermini et al., 2011). At the same time, a 40–
60% content of C-G bases promotes a stronger hybridization
due to higher contribution of stacking interactions during
hybridization, hence contributing to the stability of the formed
hybrid (Hormeño et al., 2011). However, excessive CG content
may lead to non-specific hybridization of other sequences
bearing also a high quantity of these nucleotides.
In some cases, the design of the probes is restricted to
a limited sequence such as the case of short NAs. This
difficulty becomes even more challenging due to their high
heterogeneity, since such sequences have isoform or homologous
sequences with differences up to the single mismatch. In these
situations, the probe design is constrained, putting at risk the
sensitivity and selectivity of the biosensor. Therefore, alternative
strategies should be considered. Certain buffer compositions have
traditionally solved cross-hybridization problems. The stability
of NA duplexes can be also compromised by the ionic strength
of the solution employed for the analyses (Tan and Chen, 2006).
Structural integrity of DNA has been found to be dependent on
the DNA affinity for monovalent cations such as K+ and Na+
(Kielar et al., 2018). Thus, buffer cation content can be fine-tuned
to obtain an appropriate selectivity. In addition, several agents
can be employed in the hybridization buffer to reduce themelting
temperature (i.e., the temperature corresponding to the midpoint
in the transition from helix to random coil) of the hybridization,
without requiring any temperature control. Formamide is a
denaturant compound that has been shown to reduce the melting
temperature in aqueous solutions, increasing the hybridization
efficiency (Fontenete et al., 2016; Huertas et al., 2016a, 2017).
Tetramethylamonium chloride (TMAC) and glycine betaine have
been reported to be isostabilizing agents, altering the melting
temperature and making the hybridization solely dependent on
oligonucleotide length, despite their GC content (Duby et al.,
2004; Napolitano et al., 2004; Schwinefus et al., 2007). The
destabilizing effect of such agents increases with increasing GC
content, with almost no effect on poly(dAdT) (Schwinefus et al.,
2013). On the other hand, some other components, such as urea,
have the opposite effect, promoting a decrease in the strength of
AT/U bonds more than GC base pairs (Schwinefus et al., 2007).
These agents can be employed alone or in combination in order
to achieve the proper hybridization efficiency depending on the
nucleotide sequence of the targets (Huertas et al., 2016b).
Enhanced target capture efficiency, and therefore, contribute
to increase the sensitivity of these biosensors, can also be achieved
by introducing nucleotides exhibiting restricted conformation
that promote the base stacking and backbone pre-organization,
such as nucleic acids (LNA) (Fontenete et al., 2016). The LNA
is a ribonucleotide homolog with a characteristic 2’-O,4’-C-
methylene bridge that can increase the melting temperature by
2–8◦C per subunit introduced into DNA or RNA oligomer.
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FIGURE 2 | Nucleic-acid biosensors surface functionalization. (A) Scheme of a standard DNA probe. (B) Different surface coverages: (i) low, (ii) high, and (iii) mixed
monolayer. (C) Gold surface immobilization strategies based on direct chemisorption (left) and on the generation of a functional layer (right). (D) Silicon surface
immobilization strategies through silanes without (left) or with (right) crosslinkers.
This configuration provides higher binding affinity and foster
discrimination of base mismatches, as well as minimize the
risk of digestion by nucleases (Bakthavathsalam et al., 2018).
Peptide nucleic acids (PNAs) are DNA/RNA analogs where
the sugar-phosphate backbone is substituted by units of N-2-
aminoethylglycine (Gupta et al., 2017). Their backbone is neutral
and generates no electrostatic repulsions, allowing a remarkable
stability toward complementary NAs. They are also able to
interact with both, DNA (Kirillova et al., 2015) and RNA (Sato
et al., 2016) duplexes and PNAs derivatives can be obtained
by chemical modification for enhanced affinity (Annoni et al.,
2016) and solubility (Sahu et al., 2011). Phosphorodiamidate
morpholino oligos (PMO) are also synthetic DNA analogs that
possess a neutral backbone of morpholine rings, which not only
provides higher solubility in aqueous solutions than PNAs, but
also more flexibility in length (Liao et al., 2017). Probes based
on triplex-affinity capture are gaining much interest for the
detection of NAs in biosensing platforms (Aviñó et al., 2019a).
NA triplexes can be induced by the interaction of DNA or
RNA molecules with a hairpin-like polypurine-polypyrimidine-
rich sequence. They have proven to increase the hybridization
efficiency of long and highly structured RNAs (Carrascosa et al.,
2012) and small RNA sequences (Aviñó et al., 2016). They
also show high potential for interacting with duplex DNA
fragments by promoting strand displacement (Huertas et al.,
2018). Functional nucleic acids (FNAs) such as aptamers have
also been developed using a combinatorial method called SELEX
(systematic evolution of ligands by exponential enrichment),
making possible to evolve NAs in test tubes to bind to a diverse
range of analytes beyond DNA or RNA with high affinity and
specificity (Liu et al., 2009). Further structural modifications of
these aptamers have been proven to outperform the aptamer
affinity (Aviñó et al., 2019b). However, biosensor applications
using this type of biorecognition elements are out of the scope
of this review. Table 1 summarizes the existing types of probes
used in NA biosensors.
Surface Functionalization for Probe
Immobilization and Antifouling Coating
Physical adsorption is the simplest immobilization method.
This approach does not require any NA modification taking
advantage of intermolecular forces such as electrostatic,
hydrophobic, and/or polar interactions (Zourob, 2010).
However, this adsorption is solely governed by physical attractive
forces between the biomolecule and the sensor surface, so that
the amount of adsorbed DNA probes cannot be controlled and
may vary along the surface, representing an important drawback
for the biosensor performance. In addition, flow-through assays
or changes in the pH or buffer composition can easily lead
to desorption of the biomolecules (Rabe et al., 2011), causing
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TABLE 1 | Different types of probes, main characteristics, target sequences, and
advantages.
Probe Main characteristics Target Advantages

































a loss of the signal and possible cross-contamination of the
surface. On the other hand, covalent immobilization approaches
involve chemical reactions to link the biomolecules to the
sensor surface by covalent bonds. Covalent linking generally
requires the modification of the oligonucleotide probe during
the synthesis process with a functional group to guarantee
the appropriate chemical bonding. Chemical grafting prevents
the release of probes into the solution, surpassing one of the
main drawbacks of physical adsorption and promoting better
sensor reproducibility. Likewise, covalent linking can reduce
the background signal coming from non-specific adsorption.
Different functionalization strategies for gold and silicon surfaces
for the development of label-free optical NA biosensors will be
introduced in the next sections.
DNA Immobilization Strategies for Gold Surfaces
Gold sensor surfaces are the most employed in plasmonic
biosensors. Chemical adsorption (i.e., chemisorption)
of thiolated molecules on gold is the most widely used
immobilization approach due to its easy preparation. This
approach takes advantage of the strong affinity of thiol atoms
toward gold surfaces (Sakao et al., 2005). Chemisorption of DNA
probes modified with a thiol linker, i.e., SH-DNA probes, is
the most straightforward approach for the development of NA
biosensors (Figure 2C), generating self-assembled monolayers
(SAMs) carrying directly the probe sequence that will hybridize
with the target. The grafting density of SH-DNA probes is
high compared to those obtained using other immobilization
methods (Peeters et al., 2008) and it is affected by the length of
the immobilized probes (Ulman, 1996), pH (Xia et al., 2010),
or the salt content of the employed buffer (Satjapipat et al.,
2001). However, a highly dense and compact DNA monolayer
is not always ideal, since it can hinder the accessibility of target
sequences due to steric and electrostatic forces, diminishing
the likelihood of hybridization and, therefore, the detection
signal (Lee et al., 2006b) (Figure 2B). Hybridization signal
can be enhanced by optimization of the DNA coverage and
surface properties with certain small-molecules that can act as
both, lateral spacers and blocking agents, such as 6-mercapto-1-
hexanol (MCH) (Satjapipat et al., 2001; Lee et al., 2006b), long
alkanethiols (Gong et al., 2006), or thiolated oligoethileneglycols
(Lee et al., 2006a). These molecules also promote the orientation
of the probe, reduce their density and improve the resistance
to non-specific adsorptions (Satjapipat et al., 2001; Gong et al.,
2006). The adsorption of poly-adenine (polyA) sequences to the
gold surface has been proposed as an alternative to SH-DNA
probes (Sohreiner et al., 2010). This approach relies on the
unusually strong interaction between adenine nucleotides
and gold.
The surface of an SPR sensor can also be modified with
a functional layer that carries various functional end-groups,
such as maleimide (Lee et al., 2007), amine (Brockman et al.,
1999), or carboxyl (Burgener et al., 2000) groups for the
subsequent covalent immobilization of the probes (Figure 2C).
Carboxyl (-CO2H) groups are widely employed, and usually
involves the covalent bonding of amine-modified DNA (NH2-
DNA) probes. This covalent coupling consists of an amide
bond formed between the primary -NH2 of the DNA probe
and the -CO2H terminated monolayer, which is previously
activated by the well-known carbodiimide-mediated chemistry.
A solution containing a mix of EDC/NHS (1-Ethyl-3-(3-
dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide) is
employed to activate the -CO2H groups by producing a NHS-
ester intermediate highly reactive to the primary amine in the
DNA probe (Conde et al., 2014).
Other strategies make use of affinity linkers, such as
biotinylated probes, which can be efficiently immobilized on
avidin/streptavidin modified surfaces (Vaisocherová et al., 2006;
Mir et al., 2008; Biagetti et al., 2018). The interaction between
avidin/streptavidin with biotin is known to be strongest protein-
ligand non-covalent bond. Once formed, it is very rapid and
remains stable even under extremes pHs and temperatures,
when dissolved in organic solutions, or in the presence of other
denaturing agents.
DNA Immobilization Strategies for Silicon-Based
Surfaces
In silicon-based NA biosensors, surface modification with
organofunctional alkoxysilanes has received widespread
application due to their considerable stability and rapid covalent
linkage (Hu et al., 2015). Although silane SAM formation
in silicon surfaces is not as straightforward as thiol SAM on gold
surfaces, it shows higher physical and chemical stability, since it
allows to implement a wide variety of chemical reactions (Bañuls
et al., 2013). Silane SAMs are obtained by a chemisorption of
trichloro-, trimethoxy-, or triethoxy molecules, onto the sensor
surface followed by condensation of this molecules with hydroxyl
groups generated at the silicon surface. The silanization reaction
will be strongly influenced by the experimental conditions,
where the most relevant parameters are the nature of the
silane, its concentration, nature of the solvent, water content,
temperature, and time (Bañuls et al., 2013). Silanes can have
different functional groups which introduce the specific surface
functionalization for the subsequent immobilization of the
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probes (Figure 2D). Amino-terminated silanes, such as APTES
(3-aminopropyltriethoxysilane), is one of the most widely used
for biofunctionalization due to their reactivity with different
functionalities, such as aldehyde, carboxylic acid, and epoxy.
APTES silane can incorporate different crosslinkers, a class of
molecules capable of linking two functional groups together,
e.g., surface groups and biorecognition elements, in solution.
BS3 (bis(sulfosuccinimidyl)suberate), a water-soluble amine-
to-amine homobifunctional crosslinker, can be employed for
the covalent bonding of NH2-DNA probes (Cardenosa-Rubio
et al., 2018). This crosslinker contains an NHS ester at each end
that enable the formation of amide bonds when reacting with
primary amines. Amino-silane surfaces can be also activated
with 1,4-phenylenediisothiocyanate (PDITC), which provide
isocyanate groups that can be reactive either to NH-DNA
probes (Hu et al., 2015), yielding thiourea bonds, or to SH-
DNA probes (Huertas et al., 2016b), forming thiocarbamate
bonds. However, the most used homobifunctional crosslinker
is glutaraldehyde, which forms a surface with aldehyde groups
that lets the formation of imines by their covalent reaction
with amine groups (Zainuddin et al., 2018). The fact that
homobifunctional crosslinkers carry two identical chemical
groups can cause undesired side effects such crosslinking
between surface groups or biorecognition elements, which can
actually inhibit the functionalization process. In this regard,
heterobifunctional crosslinkers can overcome those side-effects
due to the different nature of their reactive groups (Jin et al.,
2003). Other silanes carry SH- as the functional groups, such as
MPTS (Mercaptopropyltriethoxysilane). Thiolated monolayers
allow rapid and simple immobilization of SH-DNA probes by
different chemistries without using any crosslinker or other
reagent, such as disulphide bond linkage (Sánchez del Rio et al.,
2007), or through thiol-ene click photochemistry (Escorihuela
et al., 2014a). The latter one can also be also employed by
activation of the thiol group at the probe to further reaction
with different functional groups at the sensor surface, such
as alkenylated and alkynylated surfaces by forming thiol-ene
and thiol-yne links, respectively (Bañuls et al., 2019). These
approaches can be enhanced by the use of polythiolated
probes, generating multiple anchor points at the sensor surface
(Bañuls et al., 2017).
Generation of Antifouling Monolayers
The performance of label-free optical biosensors may be
compromised by interfering effects that produce refractive
index changes unrelated to the analyte binding, referred to
as fouling effects (Vaisocherová-Lísalová et al., 2016). When
the target molecules are contained in a complex solution,
the specific response due to their capture may be concealed
due to the adsorption of non-target molecules. These fouling
effects can be particularly significant during the analysis of
complex clinical samples such as blood plasma, serum, or
urine. There are many non-specific interactions between the
surface and the complex matrix components such as hydrogen
bonds, hydrophobic, electrostatic, and/or polar interactions
making the reduction of the background signal a difficult task.
Circulating NAs are present in very low concentrations compared
to other biomolecules (e.g., proteins, lipids, etc.), further
hindering their specific detection in real samples. Therefore, the
development of biosensor strategies for the analysis of complex
solutions directly without the need for any purification steps
is on demand. Several reviews have been published describing
different low-fouling coatings for label-free optical biosensors
(Liu et al., 2016; Vaisocherová-Lísalová et al., 2016).
A common approach to reduce the fouling effects is
the addition of different surfactants (e.g., Tween), protein-
based additives (including BSA or casein), or non-protein
reagents. These approaches minimize any hydrophobic
and/or electrostatic attractions between the complex matrix
and the functionalised surfaces. Unfortunately, they have
limited antifouling properties (Vaisocherová et al., 2009).
Functionalization methods should enable the immobilization of
biorecognition elements and include components that provide
a low-fouling background in complex solution. Hydrophilic
surfaces are particularly amenable for NA hybridization because
they facilitate exposure of hybridizing bases (Chen et al., 2010b).
Low-fouling surfaces based on poly(ethylene glycol) (PEG) and
its derivatives have been used widely to solve the problems
arisen in the analyses of complex solutions (Blättler et al., 2006;
Soler et al., 2014). PEG molecules create a brushed coating
on the surface, which has proven to successfully prevent and
reduce non-specific adsorption of proteins due to its hydrophilic
properties (Soler et al., 2014). In addition, recent advances
in polymer chemistry have led to the development of various
polymer coatings (e.g., zwitterionic and non-ionic polymer
brushes) with high resistance to fouling from complex biological
fluids (Rodriguez-Emmenegger et al., 2011).
Amplification Strategies
Amplification strategies facilitate the identification and
quantification of extremely low-concentrated samples or
small targets which do not have enough mass, size, and/or
concentration to generate a significant change in the refractive
index when they are analyzed with a label-free optical biosensor.
These approaches are very convenient when the sensitivity of
the transducer does not range the required physiological levels.
Several amplification strategies have been reviewed for optical
biosensing elsewhere (Zhou et al., 2018a,b). Here we summarize
some of the most employed strategies (Figure 3).
Enzyme-Based Amplification
This amplification approach makes use of an enzyme (most
often DNA polymerase) to create a large number of copies
of a specific NA. The most widely employed technique in
biology is the well-known polymerase chain reaction (PCR).
To amplify the analyte, it is necessary to increase the number
of copies of the target sequence, increasing its concentration,
prior to the interaction with the biosensor. PCR can be very
effective, however it presents a number of challenges, like the
requirement for sophisticated technology, for example thermal
cyclers, which delay the detection times (Martzy et al., 2019).
Isothermal PCR is a PCR-based strategy that is carried out at a
constant temperature, increasing the speed of analysis, avoiding
alternating temperature cycles. It enables higher amplification
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FIGURE 3 | Amplification strategies. (A) Enzymatic reaction. Nuclease digests the probe and the target can be recycled to hybridize with another probe.
(B) Self-catalytic reaction. Hybridization chain reaction starts when target hybridizes with the hairpin probe. It triggers the coupling of two partially complementary DNA
sequences called DNA helpers. (C) Protein binding nucleic acids. Anti-DNA-RNA antibody recognizes DNA-RNA hybrids. (D) Nanomaterials. Functionalized AuNPs
generate DNA sandwich structures with the hybrids.
efficiencies in less amount of time compared to traditional PCR
(Yoon et al., 2015). Asymmetric PCR (aPCR) preferentially
amplifies one strand of the original DNA over the other,
allowing selective generation of single stranded DNA (ss-DNA)
amplicons by introducing one of the PCR primers at a much
larger concentration during amplification (Graybill et al., 2018).
These products will easily hybridize with conventional duplex
DNA probes by nucleotide complementarity without requiring
any DNA denature step. These different approaches are usually
performed prior to hybridization of the target to the probe
at the sensor surface. However, other amplification methods
act once the probe is attached to the sensor surface and use
it as the initiator of the amplification process. The rolling
circle amplification (RCA) strategy employs padlock probes
(PLPs), which are single-stranded NA probes that consist of




ends that hybridize with the
target sequence, a sequence that interacts with the capture
probes, and a universal primer binding site that generate
repeated sequences. Once the target sequence is recognized,
it is enzymatically joined by DNA ligase forming a circular
probe-target complex. This is then amplified isothermally,
generating concatenates of ss-DNA with multiple repeats of
the complementary sequence (Dean et al., 2001). Xiang et al.
(2015) identify Mycobacterium genomic DNA with a detection
limit of 10 pM by employing a SPR biosensor and AuNPs
for amplification.
Nucleases can be seized for signal amplification allowing
recycling of the target due to the digestion of the probe. These
enzymes can hydrolyse the phosphate diester bond between
nucleotides, degrading NAs (Figure 3A). Ki et al. (2019) andWei
et al. (2018) used nuclease to free a DNA initiator that generate
DNA sandwiches, leading a LoD for miRNA detection of 2.45
and 0.15 picoMolar (pM), respectively. In a similar way, RNase
H can be used to degrade miRNA capture probes to recycle
the cDNA target, amplifying the sensor signal. Ho et al. (2017)
developed a biosensor to identify miR-29a which is a biomarker
of influenza infection.
Self-Catalytic Amplification
There exist methods based on enzyme-free amplification which
can achieve augment the copy number without enzymes or
amplification labels, using protocols that are simpler, more
stable and lower-cost. Hybridization chain reaction (HCR) is
a self-catalytic amplification strategy which initiates when the
target hybridizes with a complementary hairpin capture probe
(Figure 3B). When the stem-loop structure of the capture probe
is unfolded, it creates a one-dimensional DNA structure, and
two partially complementary DNA hairpins couple with it and
trigger the hybridization reaction, producing copolymers which
amplify the sensor signal (Dirks and Pierce, 2004). This process
can be enhanced by the use of a hairpin-free system in which ds-
DNA monomers assembled into a dendritic nanostructure when
it interacts with a trigger sequence which initiates the non-linear
HCR (Ding et al., 2017).
Another approach consisting of Catalyzed Hairpin Assembly
(CHA) has achieved an SPR signal amplification during miRNA
analysis (Li et al., 2016a). Recognition of miRNA target off-chip
by a hairpin (H1) triggers the interaction of the latter with a
second hairpin (H2). This interaction releases the miRNA target
for cyclic reuse and CHA products are generated creating more
than 100-fold amplification. The main drawback from traditional
CHA is the background signal generated by the non-specific
CHA products when the target is not present. To overcome this
limitation, mismatched base pairs can be introduced into the
breathing sites of the hairpins (Li et al., 2016b).
Protein Binding Nucleic Acids
One of most commonly employed amplification strategies is
the use of a specific antibody directed to DNA-RNA hybrids
(i.e., anti-DNA-RNA antibody) (Boguslawski et al., 1986). The
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antibody will bind to the DNA-RNA duplexes leading to a
signal proportional to the concentration of the hybridized
RNA (Figure 3C). This allows for the quantification of RNA
concentrations out of the range of the detection limit of
the biosensor. The main advantage of the antibody is that
it recognizes hybrids regardless of the sequence, allowing
multiplexed measurements (Schmieder et al., 2016; Sguassero
et al., 2019). This approach is of interest for the detection of
short RNA sequences, which can be difficult to amplify through
PCR or related methods. Also, it shows very rapid time-to-result
and may enable three orders of magnitude improvement of the
detection limits.
Nanomaterials
The high molecular weight of nanomaterials can be exploited
to increase the refractive index change for each target binding
event by an increment of the mass on the sensor surface.
Gold nanoparticles (AuNPs) are used frequently for signal
amplification in label-free optical biosensors, especially in
plasmonic ones. These nanoparticles are usually functionalised
with specific molecules that are able to interact with the
hybridized target at the sensor surface, such as complementary
DNA probes that create super sandwich structures (Figure 3D)
(Vaisocherová et al., 2015; Liu et al., 2017; Melaine et al.,
2017) or anti DNA-RNA hybrid antibody (Sguassero et al.,
2019). Gold nanoparticles not only increase the mass, but it
has also been shown that the local SPR of the particle can lead
to further increase in the apparent effective refractive index
due to a phenomenon called coupling effect. The coupling
effect is a distance dependent factor, achieving maximum
enhancement within 8 nm distance of the particle from the
surface for 20 nm diameter AuNPs. Outside this distance,
the size/mass properties are the major factors in the signal
improvement (Hong and Hall, 2012). Similar properties
have been demonstrated with gold nanorods, enabling SPR
signal enhancement for the detection of miRNAs at the
femtomolar level (Hao et al., 2017). In addition, graphene
sheets can be enriched with AuNPs, forming graphene
oxide-AuNPs composites (GO-AuNPs) that can offer the
physicochemical properties of both materials. Additionally,
GO-AuNPs can be used in two ways: as sensor substrate,
providing a high surface area to significantly increase the
immobilized bioreceptors; and as an amplification element
(Li et al., 2017). Gold nanoparticle-decorated molybdenum
sulfide (AuNPs-MoS2) can also be created by enriching the
edge or defective sites of MoS2 sheets with gold nanoparticles
(Nie et al., 2017).
MICROFLUIDICS SYSTEMS FOR NA
ANALYSIS
The unprecedent development of label-free optical biosensors
due to technological evolution from macro, to micro,- and
nanotechnologies has been further enhanced by integration with
microfluidic circuits. Conventional microfluidic devices rely on
the continuous flow of liquids in channels of a few microns
usually fabricated using soft-lithography methods (Luka et al.,
2015). They are mostly fabricated in polymer material such
as polyethylmethacrylate (PMMA) and polydimethylsiloxane
(PDMS) due to their excellent chemical, physical, andmechanical
properties, and excellent biocompatibility. Microfluidics have
been harness for label-free NA detection, and is a very promising
platform for parallelization of analyses, increasing the flow-
throughput of the sample while minimizing sample volumes,
which significantly reduces the cost of the assays (Baratchi
et al., 2014). Microfluidics has enabled the label-free detection of
different NAs such as mRNAs (Huertas et al., 2017) or miRNAs
(Graybill et al., 2018) in multiplexed devices by the creation of
independent parallel channels that allow sample delivery over
specific biosensors.
In addition, different microfluidic designs can be fabricated
on a single chip and disposed in customized arrangements
to perform different procedures (Jung et al., 2015). This is
of particular interest in NA analyses, since protocols usually
involve multiple steps, such as sample lysis to expose NAs found
in the cells or exosomes, their purification and extraction or
their amplification to increase the target copy number before
the eventual detection by the biosensors, as discussed in the
previous section. mRNA isolation has been achieved by the
purification with oligo (dT) that selectively hybridize to the
poly (A) tail found mRNAs, achieving up to 70% efficiency
(Satterfield et al., 2007). The functionalised photopolymerized
monolith was employed to purify mRNA from eukaryotic cell
total RNA. An RNA isolation microfluidics have been developed
capable of obtaining high-quality RNA from different biological
samples within 30min (Yoon et al., 2018). This device took
advantage of the capability of dimethyl adipimidate agent to
bind to RNA in a pH-dependent and reversible manner, avoiding
the employment of chaotropic salts or spare solvent. The non-
chaotropic nature of this molecule allowed to simplify the
isolation process and highly reduced any contamination derived
from the conventional methods, enhancing the quality of the
extracted RNA (≈87% recovery rate). Similarly, non-chaotropic
agents can be applied for DNA extraction and the potential
of this methodology has been demonstrated for the analysis of
genetic and epigenetic alterations (Shin et al., 2014), leading to
high quality and quantity of DNA purification from urine and
blood samples. The high quality of the extracted material enables
further on-chip amplification through PCR-based methods to
increase the sensor sensitivity. Haber et al. (2017) developed
a microfluidic platform for qPCR integrated with an LSPR
biosensor. The microfluidic PCR chip utilized piezoelectrically-
pumped recirculating flow. They demonstrated multiplexed
detection of E. coli DNA target amplification within 15min,
achieving a LoD of 5 fg/µL. Also, an integrated microfluidic PCR
device and an SPR-fiber sensor has allowed DNA amplification
of Salmonella spp. and its downstream label-free detection
(Nguyen et al., 2017). In this case, a serpentine micro-channel
was fabricated over two copper heat blocks, allowing on-chip
thermal cycling.
These findings highlight the potential of combining label-
free optical biosensors with different microfluidic modules
for a faster and more user-friendly operation. In addition,
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automated microfluidics for NA analyses can be achieved by
incorporating a series of microvalves and micropumps (Kim
et al., 2012). These automated circuits have been proven to be
of considerable value when integrated to multiplexed photonic
chips (Szydzik et al., 2017), presenting considerable advantages
in the fabrication of LoC platforms (Jung et al., 2015). All in all,
microfluidic integration empowers label-free optical biosensors
with exceptional capabilities and contribute to the development
of portable and user-friendly devices which can be used at the
doctor’s office or the patient’s home (González-Guerrero et al.,
2016; Lopez et al., 2017).
APPLICATIONS FOR CLINICAL DIAGNOSIS
DNA Punctual Mutations
SNPs are produced by the change of a single nucleotide for
another one within a gene sequence. This means that the
translation process from mRNA to protein might suffer some
alteration resulting in no translation of a protein, incorrect
folding or translation of a non-functional protein. The percentage
of SPNs in human samples is typically very low and the specificity
required should have resolutions at the single nucleotide level.
Therefore, in the last years, the efforts have been focused in
increasing the sensitivity and specificity of SNP analysis through
different label-free optical biosensor approaches in a faster and
less laborious manner (Table 2). Nguyen and Sim (2015) used an
LSPR based on scattered Rayleigh light from gold nanoparticles
to identify E545K and E542K mutations in PIK3CA gene from
ctDNA. They biofunctionalized gold nanoparticles with a specific
PNA to promote the specificity at the single mismatch level,
which is an important requisite for NA detection. These PNA
hybridized 100% with ctDNA and mismatched with normal
circulant DNA, achieving a limit of detection of 200 fM. In
addition, this methodology also enabled recognition of the DNA
methylation profile of the captured sequences by immunogold
colloid functionalised with anti-5-methylcytosine (anti-5-mC)
antibody, obtaining an enhanced LSPR resonant signal only from
the methylated DNA due to the presence of the immunogold
colloids. Through this secondary detection approach, they were
able to identify 2 mCpG sites on the ctDNA and improve the
detection limit by a factor of four. Another LSPR biosensor
was developed to compare the hybridization rates of perfectly
matched and mismatched sequences that only differed in one
nucleotide in codon 12 of KRAS gene (Rapisarda et al., 2017). In
this study, SH-DNA probes were employed for a direct and label-
free detection of the sequences, achieving LoD of 10 and 13 nM,
respectively. They also evaluated the hybridization rates from
a mix of perfect/mismatched sequences with different ratios.
The non-specific interactions of the mismatched sequence with
the capture probe suggested that the development of different
bioreceptors, such as PNA or new bioreceptors could improve the
specificity and the selectivity. Indeed, a new neutralized chimeric
DNA analog bioreceptor was developed to detect perfect matched
sequences, discriminating mismatched ones (Huang et al.,
2018). The chimeric DNA probes contained four methylated
nucleotides in the backbone for charge neutralization and a NH2
group in the 5’-end for its immobilization in a glutaraldehyde-
activated SAM. By using an SPRi biosensor, they evaluated the
efficiency of this new bioreceptor to discriminate sequences
that differed in a single nucleotide, demonstrating a favorable
hybridization of perfectly matched DNA sequences with their
chimeric probe under specific conditions of temperature and
ionic strength. The activity of this chimeric DNA could be
potentially enhanced by carefully designing probes sequences
with different methyl sites.
Jin et al. (2017) developed a micro-ring resonator sensor
combined with isothermal solid-phase amplification/detection
(ISAD) to identify G12D and G13D mutations found in codon
12 and codon 13 of KRAS gene from 70 colon rectal cancer tissue
samples (Figure 4A). The sensor surface was functionalized with
G12D or G13D mutant primers followed by an on-chip ISAD.
Since only the mutant primers were immobilized, mutant alleles
were specifically amplified from the clinical samples while wild-
type ones displayed no sensor signal. The ISAD-KRAS approach
showed more specificity and selectivity than PCR and direct
sequencingmethods, detecting samples containing only 1% of the
mutant allele compared to the 30% shown by these techniques.
By evaluating 70 cases of colorectal cancer, ISAD-KRAS detected
even cases where PCR and direct sequencing did not have
sufficient sensitivity. A similar approach was followed by Liu
et al. (2015b) to identify punctual mutations in the EGFR gene,
specifically, the L858R mutation. They identified 1% of mutant
alleles in a sample of mixed cellular types in contrast with the 25%
achieved by PCR. Moreover, they evaluated lung cancer patient
samples, correctly detecting the L858R mutation in samples that
were also detected by direct sequencing. It was also possible
to identify cases that the PCR could not detect due to the
low amount of DNA. Both ISAD-based approaches have been
demonstrated to be promising diagnosis tools for SNPs analyses
and appealing alternatives to PCR and sequencing methods due
to their fast operation time (<30min), sensitivity, specificity, and
cost-effective relation.
TABLE 2 | Optical biosensors for DNA punctual mutations detection: mutations, genes involved, real samples analyzed, and limit of detection achieved.
Sensor SNP Sample LoD Amplification References
LSPR E545K and E542K (PIK3CA) ctDNA in plasma 200 fM
50 fM
Immunogold colloids Nguyen and Sim, 2015
LSPR codon 12 of (KRAS) Buffer 10 nM and 13 nM NA Rapisarda et al., 2017
Micro-ring resonators G12D and G13D in KRAS Colorectal cancer tissue 1% mutant allele ISAD Jin et al., 2017
MZI L858R in EGFR Lung cancer tissue 1% mutant alleles ISAD Liu et al., 2015b
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FIGURE 4 | Detection of SNPs and methylation profile with optical biosensors. (A) Detection of two SNPs in KRAS gene using silicon microring resonators sensors. (i)
ISAD-KRAS assay representation and calibration curves reflecting the resonant wavelength shift obtained for G12D and G13D mutants of KRAS gene (gray: wild-type,
black: G12D mutant, red: G13D mutant). (ii) Validation of the ISAD-KRAS assay in 70 clinical samples of colorectal cancer patients (50 mutants and 20 wild-type) for
G12D and G13D mutations, and comparison with conventional techniques as PCR and sequencing. Purple oval represents the mutant area and yellow oval the
wild-type one. The mutant allele (black) and wild allele (blue) are also shown. Readapted with permission from Jin et al. (2017). Copyright © 2017 Jin et al. Creative
Commons Attribution License 3.0 (CC BY 3.0). (B) Detection of the methylation profile of PAX-5 gene using a SPR biosensor. (i) Scheme and real-time recognition of
the two-step assay developed for the detection of (1) ds-DNA fragments and (2) 5’methyl cytosines by the PPRH probe and specific anti-5-mC antibody, respectively.
(ii) Identification of different methylation profiles (0x, 1x, and 4x 5’ methyl cytosines). Reprinted from Huertas et al. (2018), Copyright (2018), with permission from
Elsevier.
DNA Methylation Profile
DNA methylation is an epigenetic mark found in some cytosines
generally located in CpG islands of most promoter regions. The
level of methylation of these regions determines the accessibility
of the transcription factor to the promoter and, therefore, the
levels of expression of the genes. Normally, the hypermethylation
of these CpGs regions are related to down-transcription and,
inversely, hypomethylation means overexpression (Rodriguez
et al., 2006). The detection of the methylation status using
label-free optical biosensors has attracted increasing attention
over the last few years (Nazmul Islam et al., 2017). As per
SNPs, the concentration of these biomarkers is rather low
in samples (Gai and Sun, 2019) (Table 3). In addition, they
should be able to specifically detect the methylation status
at the single cytosine resolution for more accurate analyses.
Yoon et al. (2015) developed a LoC device based on micro-
ring resonators and bisulfite conversion methodology. Bisulfite
is a carcinogenic compound which converts the non-methylated
cytosines into uracil whereas methylated cytosines remain intact.
A pre-processing module including a microchamber for bisulfite
treatment, a micromixer that passively mixed the sample, and
a DNA-purification microchannel were integrated on the same
chip and coupled to a detection module. After the purification
step, an ISAD was performed using methyl- and unmethyl-
specific primers grafted in micro-ring resonators for the analysis
of the methylation profile of RARβ gene from genomic DNA
of MCF-7 cells. Methylated sequences produced a shift in the
resonant wavelength of the resonator immobilized with methyl-
specific primers, whereas no amplification was observed in the
resonator functionalised with the unmethyl-specific ones. The
described LoC enabled identification of methylation levels of
1% in a mix of methylated/unmethylated DNA compared to
the 10% achieved by RT-PCR. It also eliminated the human
errors introduced during the manual bisulfite treatment and
could identify the DNA methylation status in only 80min of
analysis, in contrast with conventional methods (24 h). However,
it did not suppress the long and intense processes related to the
bisulfite conversion. In addition, bisulfite conversion cannot be
used to identify other epigenetic marks generated by enzymatic
oxidization and that are highly important for the assessment
of the methylation process, such as of 5-mC, such as 5-
hydroxymethylcytosines (5-hmC), 5-formylcytosine (5-faC), and
5-carboxylcytosine (5-caC) (Chowdhury et al., 2014). Due to this
lack of versatility, other detection approaches have been pursued.
Methyl-cytosines and their derivatives can be specifically
analyzed by the employment of specific antibodies and proteins.
Kurita et al. (2015) designed a microfluidic device to measure
DNA methylation in an SPR sensor. They mixed fragmented
DNA with a biotinylated bulge inducer probe, exposing the
cytosine in a looped-out conformation. Then, this DNA-bulge
complex was attached on a streptavidin surface by streptavidin-
biotin interaction. Finally, they identified the methylated
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TABLE 3 | Optical biosensors for DNA methylation profiles identification: genes involved, real samples analyzed, methodology employed, and detection limit reached.
Sensor Gene Sample Methodology LOD Amplification References
SPR Synthesized ODN genomic λ DNA and HCT116
human colon cancer cells
biotinylated bulge inducer probe/
anti-5-mC





Single-cytosine NA Huertas et al., 2018
SPR MGMT promoter gene genomic λ DNA alkylating linker
molecule/anti-5-mC
25% NA Kurinomaru et al., 2017




Single-cytosine NA Nguyen et al., 2015
Micro-ring
resonators




ISAD Yoon et al., 2015
Toroidal resonant
cavity
Synthesized ODN Buffer Anti-5-hmC 0.42 pM NA Hawk and Armani,
2015
cytosine using an anti-5-mC antibody, achieving single-cytosine
resolution in 48 fg of genomic HCT116 human colon cancer
cells. The simplicity and miniaturization of the microfluidic
sensor offer great advantages for this methodology. Nevertheless,
a denaturalization step off-chip is necessary to allow the target
hybridization with the bulge inducer probe, which leads to
an increase in the detection time. Different approaches have
been developed in order to directly capture intact ds-DNA
targets without the need for denaturalization steps, resolving
the problem of the direct analysis of ds-DNA molecules.
DNA methylation status has been analyzed by the direct
immobilization of ds-DNA on gold surfaces by employing an
alkylating linker molecule, L1 (Kurinomaru et al., 2017). This
molecule consists of two reactive groups, nitrogen mustards,
that interacts with DNA, and cyclic disulphides, attaching
to the gold substrate. Using an SPR biosensor, they directly
immobilized methylated ds-DNA on the gold sensor surface and
assessed the methylation levels employing anti-5-mC antibody.
This approach could be a promising tool to decipher global
methylation status but lacks specificity for concrete DNA
methylation sequences. Much of hybridization-based analytical
techniques struggle to capture ds-DNA due to the use of
probes which analytical performances are limited to duplex
formation. Alternative approaches have been implemented to
overcome such limitation. Nguyen et al. (2015) employed an
LSPR biosensor based on gold nanostars and Rayleigh resonance
to assess the methylation profile of p53 gene promoter. They
biofunctionalized the gold surface with a specific PNA, which
enables to form stable complexes with ds-DNA. They quantified
the methylation status of the captured ds-DNA target by specific
interaction with methyl-CpG binding domain protein 2. This
biosensor achieved a limit of detection down to the single-
cytosine and it was applied to DNA samples from HeLa and
HEK 293 cells-extraction. Moreover, it allowed the study of
conformational changes of p53 gene promoter and the relative
transcriptional efficiencies regulated bymethylation, highlighting
its potential as a tool to study the effects generated by the presence
of this epigenetic mark. Huertas et al. (2018) also achieved a
direct detection of ds-DNA and the evaluation of methylation
status employing an SPR biosensor within 30min. They used
a novel bioreceptor based on poly-purine reverse-Hoogsten
hairpin (PPRH) probes that permitted the direct recognition
of ds-DNA by inducing strand displacement and promoting
triple-helix formation (Figure 4B). The PPRH probe presented
8-aminoG modifications to enhance the strength of the capture,
which further increased the stabilization of the triple helix
structure. The efficient capture of ds-DNA fragments allowed to
quantify and assess different methylation profiles (from 1 to 4
cytosines) in PAX-5 gene promoter through immunodetection
using anti-5-mC antibody.
DNA methylation analysis based on immunodetection allows
for the investigation of other epigenetic modifications rather
than 5-mC, which can be detected by employing the specific
antibodies for each one. Hawk and Armani (2015) employed
a toroidal resonant cavity sensor for the identification of DNA
containing 5-hydroxymethylcytosines by using a specific anti-
5-hmC antibody. In this case, instead of using a DNA probe,
they attached the antibody to the sensor surface. Hence, direct
detection of synthetized ds-DNA with methylated, unmethylated
and hydroxymethylated epigenetics modifications was carried
out, showing a limit of detection of 0.42 pM and demonstrating
the versatility of the assay for different epigenetic modifications.
Long RNAs
Long RNAs are characterized by a length from 200 bases up to
several kilobases. They can be classified as coding RNAs and non-
coding RNAs depending on if they encode the information (i.e.,
mRNA) for the synthesis of proteins or not. The latter ones have
structural [transfer RNA (tRNA), ribosomal RNA (rRNA), small
nuclear RNA (snRNA)] and regulatory roles [Long intergenic
non-coding RNAs (lncRNAs); Natural Antisense Transcripts;
Promoter associated ncRNAs, etc.] (Carrascosa et al., 2016). One
advantage of long-RNA biosensing is the large refractive index
changes they produce due to their largemases, which is translated
to higher sensor signal intensities. Table 4 summarizes different
strategies for long RNA biosensing.
Messenger RNAs
mRNA analysis gives information about the translation of a
particular protein, allowing even the identification of the cell
types that are suffering changes in the translation process
that might be related to the beginning of some forms of
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TABLE 4 | Optical biosensors for long RNAs detection: type of RNA, real samples analyzed, strategies to improve the sensitivity, and the demonstrated limit of detection.
Sensor RNA Sample LOD Amplification References
SPR Fas57/Fas567 mRNA alternative
splicing
HeLa cell total RNA 387/438 pM NA Huertas et al., 2016a
SPRi 16S rRNAs L. pneumophila, P.auriginosa and
S.typhimurium total RNA





Patient-derived xenograft GBM6 RNA C(t) values aPCR Cardenosa-Rubio et al.,
2018
BiMW Fas57/Fas567 mRNA alternative
splicing
Buffer 580/735 fM NA Huertas et al., 2017
diseases. Discrimination among the diverse mRNAs transcripts
is essential. Alternative splicing process can generate different
mRNA isoforms from a common pre-mRNA. These isoforms
share common exon sequences that might result in cross-
hybridization. For all these reasons, a small number of label-
free optical biosensors have been developed for monitoring
alternative splicing processes for diagnostic purposes. Huertas
et al. (2016a) developed an SPR biosensor for the direct
quantification of Fas gene alternative splicing mRNA isoforms
(Fas57/Fas567, Figure 5A). Prior to detection, they optimized
a fragmentation step based on RNA alkaline hydrolysis to
customize the isoforms’ length to the biosensor convenience
(≈200-bases fragments). This strategy allowed to overcome the
challenge encountered in the detection of long RNA molecules
and open the door to explore new biomarkers in evanescent-
wave optical biosensors based on long RNA targets. For detection,
they immobilized SH-DNA probes on the gold sensor surface
containing the splice-junction sequences, the key feature for
the specific recognition of each isoform. Also, they optimized
a highly stringent buffer by adjusting with the formamide
content and the ionic strength, achieving 100% selectivity and
a limit of detection of 387/438 pM for each isoform. The
methodology was validated by evaluating purified RNA samples
from different HeLa cell lineages, which were in good agreement
with conventional RT-qPCR-based methodology. In addition,
further implementation in a multiplexed BiMW biosensor
outperformed the SPR biosensor, exhibiting LODs with three
order of magnitude improvement thanks to the high sensitivity
of these interferometric biosensors (Huertas et al., 2017).
Ribosomal RNAs
Ribosomes are hybrid complexes formed by proteins and
rRNA sequences that forms part of a large ribosomal subunit
and a small one. Although the different subunits have highly
conserved molecular weights and sequences, they differ among
organisms, enabling creation of phylogenies and identification
of the microorganisms. rRNA is present in high concentrations
inside the cell, but its secondary structure may hinder the
recognition event by DNA probes, limiting the sensitivity.
Melaine et al. (2017) used a SPRi sensor for the simultaneous
detection of 16S rRNAs (a component of the small ribosomal
subunit in procariotes) from three pathogenic bacterial strains:
L. pneumophila, P. aeruginosa, and S. typhimurium (Figure 5B).
They selectively captured the targets by duplex DNA probes
at the sensor surface. Subsequently, they performed a signal
amplification based on Au-NP functionalized with a DNA probe
specific to a second target region of the previously captured
rRNA sequences. The amplification approach resulted in a 3-
fold increase of the SPR signal, achieving a limit of detection
of 10 pg/mL and a range of detection of 0.01–100 ng/mL, which
covers the wide dynamic range of recognition necessary for the
detection of the NA expression dynamics as highlighted in the
challenges. Total RNA from the different bacterial cultures were
analyzed after RNA extraction and fragmentation by a multiplex
approach that allowed to detect in a selective and fast way 16S
rRNA from the three different bacterial strains.
Long Non-coding RNAs
The first lncRNA discovered and studied was H19 (Huang et al.,
2019). Since then, many additional lncRNAs have been identified
and investigated as they interfere in several biological functions.
For example, KIAA0495/PDAM can act as tumor suppressors
in oligodendrioglioma while MALAT1 (metastasis associated
lung adenocarcinoma transcript 1) is related to different
tumors being able to act as tumor suppressor in glioblastoma.
Cardenosa-Rubio et al. (2018) used a micro-ring resonator for
the multiplexed detection of the three lncRNAs (Figure 5C).
They carried out a PCR amplification prior detection, allowing
the subsequent hybridization of the generated ss-DNAs with
complementary DNA probes spotted in array distribution in
the silicon sensor surface. The selected lncRNAs were tested in
spiked-in commercial brain and lung total RNA samples and in
RNA from glioblastoma cell line (GBM6). Results were validated
by RT-qPCR and showed high consistency with results from
precedent literature.
Short Non-coding RNAs
Small RNAs are characterized by a short length around 20–200
bases and they englobe microRNAs (21–25 bases), piwiRNAs
(20–30 bases), tinyRNAs (<22 bases) and small interfering RNAs
(20–25 bases). All play a structural or regulatory role so they are
called small non-coding RNAs because they are not translated
into proteins (Carrascosa et al., 2016). Most label-free optical
biosensors have been harnessed for the detection of miRNAs
(Table 5). Schmieder et al. (2016) employed an SPR biosensor
to detect miRNA-93. To maximize both, the selectivity and
sensitivity of the SPR detection, they used a SH-LNA probe and
subsequent amplification by anti-DNA/RNA hybrid antibody,
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FIGURE 5 | Detection of long RNAs with optical biosensors. (A) Quantification of alternatively spliced mRNA isoforms from Fas gene using a SPR biosensor. (i)
Scheme of the different RNA isoforms generated by alternative splicing of Fas gene. (ii) Calibration curves for Fas57 and Fas567 isoforms and scheme of the
DNA-probes used for the hybridization. (iii) SPR sensograms of the detection of total extracted HeLa cell RNA for Fas56 (left) and Fas57 (right) probes. Reprinted from
Huertas et al. (2016a), Copyright (2016), with permission from Elsevier. (B) Detection of 16S rRNA from Pseudomonas aeruginosa, Salmonella typhimurium, and
Legionella pneumophila using a SPRi sensor. (i) Capture probes (CP) are immobilized for the hybridization of RNA and amplification is performed by using
nanoparticles functionalized with the detection probes (GNP-DP). Probe strategy design are illustrated using 16S rRNA sequence of Pseudomonas aeruginosa as an
example. (ii) SPR sensograms and calibration curves for quantification of L. pneumophila RNA strain using amplification. Adapted with permission from Melaine et al.
(2017). Copyright © 2017 American Chemical. (C) Detection of KIAA0495 and MALAT1 lncRNAs with microring resonator arrays. (i) Scheme of the overall assay for
lncRNA detection. (ii) Identification of each lncRNA and evaluation of the specificity using β-actin as internal control. (iii) Assessment of lncRNAs expression in GBM6
cells compared to conventional, single-plex RT-qPCR technique. Healthy brain (1) and lung (2) tissues were used as reference. Republished with permission of The
Royal Society of Chemistry from Cardenosa-Rubio et al. (2018); permission conveyed through Copyright Clearance Center Inc.
enhancing the sensor response by one order of magnitude.
Enhanced amplification can be achieved by the combination of
this antibody with Au-NPs. Sguassero et al. (2019) introduced
a multiplexed SPRi biosensor for the detection of four miRNAs
potentially involved inmultiple sclerosis. The antibody permitted
the recognition of the different miRNA sequences selectively
hybridized on the sensor surface, producing an enhanced SPRi
signal correspondent to the concentration of captured miRNAs.
This approach was used to analyse to RNA extracted from
blood samples from multiple sclerosis patients and succeeded in
detection of relevant miRNAs at the sub-picomolar range.
The versatility of label-free optical biosensors allows
integration of different amplification methods within the same
assay. Wei et al. (2018) employed an SPRi biosensor for the
multiplexed assessment of miR-21 and miR-192 in buffer.
In order to increase the sensitivity, they integrated strand
displacement amplification (SDA) with gold nanoparticles.
To do so, they designed hairpin probes for the amplification
that consisted of three different domains, including the
miRNA-recognition sequence, an amplification domain and a
common recognition domain which hybridizes with both, a
SH-DNA probe immobilized at the sensor surface and the gold
nanoparticles. The different miRNAs interacted specifically with
their recognition sequence in each amplification probe, causing
the opening of the hairpin probe loop and initiating the SDA.
Finally, the released triggers hybridized with the captured probes
on the sensor surface and the DNA functionalized AuNPs,
producing a strong change in mass with a correspondingly large
signal. This method was capable of simultaneously detecting
miR-21 and miR-192 at the low picomolar range in 10% diluted
bovine serum. An analogous strategy was developed by Ki et al.
(2019) (Figure 6A). They used an LSPR biosensor based on
gold nanostars to detect miR-10b in urine and plasma samples
from mice with orthotopic Hs746tT xenografts. Amplification
was performed by duplex-specific nuclease that degraded the
DNA probe in DNA/RNA hybrids, recycling the target and
liberating a DNA initiator. DNA initiator was captured creating
a DNA sandwich with DNA helpers and tannic acid gold
nanotags, allowing 2.42 pM LoD. Results showed that miR-10b
concentration was higher in plasma than in urine samples.
Dual amplification was achieved by the generation of two
layers of GO-AuNPs composite in an SPR sensor (Li et al., 2017).
The bottom layer served as a surface for the immobilization of
SH-DNA probes on the nanoparticles, providing functionality to
the sensor. In a second step, the target miRNA was hybridized
with the immobilized probes and subsequently interacted with
DNA functionalized GO-AuNPs composites, forming the upper
layer that acted as a enhancer of the sensor signal. They showed
one order of magnitude LOD improvement in the two-layer
approach compared to the performance of the single layer
used as a substrate, achieving extremely sensitive detection (0.1
fM) of miRNA-141 extracted from different cancer cell lines.
In addition, they obtained corresponding levels of expression
with RT-qPCR. A similar strategy was developed based on gold
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TABLE 5 | Optical biosensors for miRNA detection: strategies to improve the sensitivity, the demonstrated limit of detection and the real samples analyzed.
Sensor Target miRNA Sample LOD Amplification References
SPR miR-145 Buffer 1 nM NA Aviñó et al., 2016
SPR miR-93 Buffer 10 pM Antibody Schmieder et al., 2016
SPR miR-141 total RNA extracted from cancer cell lines
(prostate: 22Rv1; hepatocellular:SMMC7721;
colon LoVo)
0.1 fM GO-AuNPs Li et al., 2017
SPR miR-21 Hepatocarcinoma cell line (Bel-7404);
SMMC-7721; L-02; Hela
0.6 fM AuNPs Liu et al., 2017
SPR miR-141 total RNA extracted from cancer cell lines
(prostate: 22Rv1; hepatocellular: SMMC7721;
colon LoVo); 10 % human serum
0.5 fM AuNPs-MoS2 Nie et al., 2017
SPR miR-21 total RNA extracted from MCF-7 cells 1 pM CHA Li et al., 2016b
SPR miR-21 total RNA extracted from MCF-7 cells < 1 pM CHA Li et al., 2016a
SPRi miR-21 and
miR-192
Buffer 0.15 pM (miR-21) and 0.22
pM (miR192)





total RNA extracted from blood 0.5 pM AuNP + antibody Sguassero et al., 2019
SPRi miR-29-3p total RNA extracted from throat swab RNase H Ho et al., 2017
LSPR miR-10b urine and plasma samples of mice with
orthotopic Hs746tT xenografts












RNA extracted surgical glioma cells Ct aPCR Graybill et al., 2018
MZI miR-21, let-7a urine (bladder cancer) and cell lines (MCF7
and A549)
1 nM NA Liu et al., 2015a
BiMW miR-181a Urine (bladder cancer) 23 aM NA Huertas et al., 2016b
nanoparticles-decorated molybdenum sulfide (AuNPs-MoS2)
as amplification element (Nie et al., 2017). SH-DNA probes
complementary to miR-141 were immobilized on an SPR
biosensor to identify miR-141 in the same cellular lines and HeLa
cells, achieving a limit of detection of 0.5 fM. Moreover, they
assessed the accuracy in spike samples diluted in 10% human
serum acquiring reliable values validated by RT-qPCR.
Other methods to increase the sensitivity during miRNA
detection are based on probe design. Aviñó et al. (2016)
synthetized a new DNA tail-clamp purine track to detect miR-
145. This probe promoted a triple helix with the RNA target,
improving 2.4 times the sensitivity over duplex forming probes.
In addition, an 8-Amino-2
′
-deoxyguanosine modification was
introduced to stabilize the triplex by 1.5 times, making this new
probe attractive for improved miRNA detection.
Graybill et al. (2018) employed amicro-ring resonator array to
analyse eight miRNAs from surgical glioma cells. They amplified
the signal using aPCR and evaluated the hybridization rate of
ss-DNA as Ct, like qPCR, achieving values of level expression
similar to the literature for surgical glioma cells. Also, a MZI
was employed for the detection of miRNAs by Liu et al. (2015a).
They identified two miRNAs (miR-21 and let-7a) that participate
in bladder cancer onset in human urine samples and obtained a
LOD of 1 fmol/µL (1 nM). In addition, they identified SNPs from
let-7 family miRNAs. Finally, attomolar detection limit of miR-
181 (LoD = 23 aM) in a direct assay (<20min) was achieved
using a BiMW interferometer (Huertas et al., 2016b) (Figure 6B).
The ultra-high sensitivity achieved reveals the potential of these
types of optical transducers for the analysis of extremely low
concentrations with no need for any amplification strategy.
They discriminated homologous miRNAs at single nucleotide
mismatched, as well as pre-miRNA-181, during the evaluation
of miR-181 in urine samples from cancer bladder patients.
These results uncovered the participation of this miRNA in the
development of bladder cancer.
CONCLUSIONS AND FUTURE
PERSPECTIVES
The employment of evanescent-wave optical biosensors for
the routine analysis of NA-based biomarkers threatens to
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FIGURE 6 | Detection of miRNAs by optical biosensors. (A) Detection of miR-10b for LSPR-based biosensor. (i) Schematic representation of miRNA detection using
duplex-specific nuclease for recycling and hybridization chain reaction with tannic acid tags for amplification. (ii) LSPR shifts in urine and plasma mice with orthotopic
Hs746tT xenografts samples compared to normal model mice. Reprinted with permission from Ki et al. (2019). Copyright © 2019, American Chemical Society.
(B) Detection of miR-181a using a BiMW interferometer. (i) Working principle of the BiMW interferometer and biofunctionalization strategy. (ii) Calibration curve of
miR-181a in semilog scale. (iii) miR-181a quantification in urine samples from healthy donors and bladder cancer patients. Adapted with permission from Huertas
et al. (2016b). Copyright © 2016, American Chemical Society.
change the concept of diagnosis. The opportunity for fast,
highly sensitive, and multiplexed analyses of the genetic and
epigenetic landscape of different diseases makes these devices
a very attractive diagnostic solution. Numerous biosensing
approaches have been proposed as solutions for use in clinical
environments. Thanks to their highly sensitive transducers
and their ease to be combined with different amplification
methods, label-free optical biosensors have allowed NA detection
in a wide dynamic range of concentrations, from nanomolar
down to attomolar. Their versatility to incorporate specialized
probes and immunodetection methods have also enhanced
the selectivity of the analysis for the identification of a great
variety of NA biomarkers, including SNPs, methylation patterns,
mRNAs, and miRNAs. In addition, these sensors are well-suited
to integration within lab-on-a-chip microsystems, enabling
further enhancement through combination with a variety of
pre- and post-processes, thanks to monolithic integration
with complex and automated microfluidic systems, ultimately
enabling the development of low-cost, multiplexed, and user-
friendly platforms.
Unfortunately, there still exist some drawbacks to be
surpassed. Most of the applications described in this work
are preclinical proof-of-concepts performed in the very
controlled laboratory environment environments. This can
difficult the complete translation of the technology to real
clinical settings. Further investigations need to be fulfilled
to confirm their feasibility which should be aligned with
internationally established guidelines. Efforts should be focused
on the development of biosensors capable of simultaneous
multiplexed analyses in a few minutes. In terms of integration,
new microfluidic approaches should be implemented to meet
the specific pre- and post-processing requirements for each
biomarker inside the same sensor platform guaranteeing and
testing their stability and reproducibility. In addition, sample
volumes should be reduced to few microliters.
On the other hand, the vast genetic and epigenetic network
makes calls for a new system for well-defined biomarker panels
linked to concrete diseases and disease stages. Extensive testing
in clinical trials is required to establish standard patterns for each
case. Future trends should be focused on leveraging integrated
microfluidics and multiplexed label-free optical biosensors to
create highly complex diagnostic, monitoring and prognostic
systems. These complex systems will unlock even more detailed
and specific information. The sheer vastness and subtlety of
the form and function of the NA biomarkers suggest that big
data and bioinformatic analysis approaches will be required to
extract useful information from these analyses. Such an endeavor
will contribute to making connections between specific diseases
and signatures. Interactivity in the form of potentially reversible
epigenetics will add an additional dimension.
On the whole, the analysis of genetic and epigenetic
biomarkers is a key requirement for the effective analysis and
understanding of important malignancies, such as infectious
diseases and cancer. The potential reversibility of genetic and
epigenetic mechanisms poses great promise in the development
of personalized treatments for each patient. Indeed, in precision
medicine, the aim is the molecular characterization of each
patient, which can only be realized by the employment of low-
cost and high throughput screening technologies. There is a lot
that can be gleaned on patient-derived data with PoC devices,
Frontiers in Chemistry | www.frontiersin.org 19 October 2019 | Volume 7 | Article 724
Huertas et al. Advanced Nucleic Acid Optical Biosensors
which can be very valuable. Such a holistic approach can also be of
value for personalized drug delivery, effectively provide tailored
medications and therapies, ensuring that the most adequate
treatment is given to the right patient with a proper dose at the
correct time.
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